AUTHOR=Zhang Nan , Zhang Haonan , Gao Bingbing , Miao Yanwei , Liu Ailian , Song Qingwei , Lin Liangjie , Wang Jiazheng 

TITLE=3D Amide Proton Transfer Weighted Brain Tumor Imaging With Compressed SENSE: Effects of Different Acceleration Factors

JOURNAL=Frontiers in Neuroscience

VOLUME=16

YEAR=2022

URL=https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.876587

DOI=10.3389/fnins.2022.876587

ISSN=1662-453X

ABSTRACT=<sec><title>Objectives</title><p>The aim of the current study was to evaluate the performance of compressed SENSE (CS) for 3D amide proton transfer weighted (APTw) brain tumor imaging with different acceleration factors (AFs), and the results were compared with those of conventional SENSE.</p></sec><sec><title>Methods</title><p>Approximately 51 patients with brain tumor (22 males, 49.95 ± 10.52 years) with meningiomas (<italic>n</italic> = 16), metastases (<italic>n</italic> = 12), or gliomas (<italic>n</italic> = 23) were enrolled. All the patients received 3D APTw imaging scans on a 3.0 T scanner with acceleration by CS (AFs: CS2, CS3, CS4, and CS5) and SENSE (AF: S1.6). Two readers independently and subjectively evaluated the APTw images relative to image quality and measured confidence concerning image blur, distortion, motion, and ghosting artifacts, lesion recognition, and contour delineation with a 5-point Likert scale. Mean amide proton transfer (APT) values of brain tumors (APT<sub><italic>tumor</italic></sub>), the contralateral normal-appearing white matter (APT<sub><italic>CNAWM</italic></sub>), and the peritumoral edema area (if present, APT<sub><italic>edema</italic></sub>) and the tumor volume (V<sub><italic>APT</italic></sub>) were measured for objective evaluation and determination of the optimal AF. The Ki67 labeling index was also measured by using standard immunohistochemical staining procedures in samples from patients with gliomas, and the correlation between tumor APT values and the Ki67 index was analyzed.</p></sec><sec><title>Results</title><p>The image quality of AF = CS5 was significantly lower than that of other groups. V<sub><italic>APT</italic></sub> showed significant differences among the six sequences in meningiomas (<italic>p</italic> = 0.048) and gliomas (<italic>p</italic> = 0.023). The pairwise comparison showed that the V<sub><italic>APT</italic></sub> values of meningiomas measured from images by CS5 were significantly lower, and gliomas were significantly larger than those by SENSE1.6 and other CS accelerations, (<italic>p</italic> &lt; 0.05). APT<sub><italic>tumor</italic></sub> (<italic>p</italic> = 0.191) showed no significant difference among the three types of tumors. The APT<sub><italic>tumor</italic></sub> values of gliomas measured by APTw images with the SENSE factor of 1.6 and the CS factor of 2, 3, and 4 (except for CS5) were all positively correlated with Ki67.</p></sec><sec><title>Conclusion</title><p>Compressed SENSE could be successfully extended to accelerated 3D APTw imaging of brain tumors without compromising image quality using the AF of 4.</p></sec>